Anti-Psychotic Drug May Help Patients With Severe Asthma

Researchers have found that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.

Asian Scientist (Oct. 30, 2013) – New research from Japan brings hope of a new treatment for asthma patients resistant to corticosteroids.

In a study published in Nature Communications, the researchers report that a type of lymphocytes called natural helper (NH) cells plays a critical role in corticosteroid resistance and demonstrate that the anti-psychotic drug Pimozide can be used to overcome resistance to steroids in severe asthma patients.

Asthma is a chronic disease characterized by a persistent inflammation of the airways. The condition can be controlled with a moderate dose of inhaled corticosteroids in most patients.

However, 5-10 percent of patients with “severe asthma” respond poorly to a maximal dose of steroids. These patients experience uncontrolled and frequent asthma symptoms that have a profound impact on their quality of life and health care costs. Unveiling the mechanism leading to steroid resistance in these patients is therefore crucial for the development of a new, effective therapy. ​

T lymphocytes and NH cells in the asthmatic lung produce proteins called interleukin (IL)-5 and IL-13 that are responsible for severe airway inflammation. In asthma patients, inhaled steroids function by suppressing both T lymphocytes and NH cells.

However, in severe asthma patients, another protein called interleukin-33 (IL-33) produced in the airways strongly activates NH cells to produce IL-5 and IL-13, leading to severe airway inflammation.

In the current study, the researchers employed an experimental mouse model for airway inflammation to study the pathway leading to IL-33-mediated NH activation. Their research shows that NH resistance to steroids is induced by the protein thymic stromal lymphopoietin (TSLP), present in the airways of severe asthma patients.

The team tested reagents that block the intracellular signals triggered by TSLP in NH cells and identified one drug, Pimozide, an approved anti-psychotic drug, that restored the effects of steroids on NH cells.

“Therefore, administration of Pimozide or related drugs would be an effective treatment in human severe asthmatic patients,” conclude the authors.

The article can be found at: Kabata et al. (2013) Thymic Stromal Lymphopoietin Induces Corticosteroid Resistance In Natural Helper Cells During Airway Inflammation.

——

Source: RIKEN; Photo: NIAID/Flickr/CC.
Disclaimer: This article does not necessarily reflect the views of AsianScientist or its staff.

Asian Scientist Magazine is an award-winning science and technology magazine that highlights R&D news stories from Asia to a global audience. The magazine is published by Singapore-headquartered Wildtype Media Group.

Related Stories from Asian Scientist